Related Experiment Video
Updated: Jun 28, 2026

08:48
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Bioelectrochemical Sensing Dynamics of SARS-CoV-2 Biomarkers
Nelia A Sanga1, Marlon Oranzie1, Jaymi L January1
1SensorLab (University of the Western Cape Sensor Laboratories), University of the Western Cape, Robert Sobukwe Road, Bellville 7535, Cape Town, South Africa.
Bioelectrochemistry (Amsterdam, Netherlands)
|June 26, 2026
Summary
Rapid advancements in bioelectrochemical biosensors offer promising solutions for SARS-CoV-2 detection. This review covers nucleic acid and antibody strategies for quick and sensitive diagnosis of the virus.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Infectious Disease Diagnostics
Background:
- The SARS-CoV-2 pandemic highlighted the critical need for efficient diagnostic tools.
- Existing methods face challenges in speed, sensitivity, and accessibility.
- Bioelectrochemical detection offers a promising avenue for rapid diagnostics.
Purpose of the Study:
- To comprehensively review recent advances in bioelectrochemical biosensors for SARS-CoV-2 detection.
- To focus on nucleic acid- and antibody-based strategies.
- To compare different biosensor designs, analytical parameters, and nanomaterial integration.
Main Methods:
- Review of literature on SARS-CoV-2 bioelectrochemical biosensors.
- Analysis of aptasensors, immunosensors, and genosensors.
- Comparison of sensitivity, detection limits, response times, and transduction mechanisms.
Main Results:
- Nucleic acid and antibody-based bioelectrochemical strategies show significant potential for SARS-CoV-2 detection.
- Aptasensors, immunosensors, and genosensors offer diverse approaches with varying advantages and limitations.
- Nanomaterials enhance sensitivity and performance of these biosensors.
Conclusions:
- Bioelectrochemical biosensors are crucial for developing rapid, sensitive, and accessible SARS-CoV-2 diagnostics.
- Further innovation in point-of-care biosensors is essential for future pandemic preparedness.
- Optimized biosensor design and nanomaterial integration are key to improving detection capabilities.
